Status:
NOT_YET_RECRUITING
Neonatologist-Performed Lung Ultrasound (NPLUS) to Guide Respiratory Therapy
Lead Sponsor:
Royal Hospital For Women
Collaborating Sponsors:
Medical University of Graz
Conditions:
PreTerm Neonate
Respiratory Distress Syndrome (RDS)
Eligibility:
All Genders
1+ years
Phase:
NA
Brief Summary
The goal of this cross-over clinical trial is to evaluate whether Neonatologist-Performed Lung Ultrasound (NPLUS) can be used in preterm babies on non-invasive breathing support to reduce the amount o...
Detailed Description
NPLUS is used to detect various artifacts that emerge due to air and fluid ratio in the lungs. The image results form a beam reflection and reverberation of echoes on tissues. The most important artif...
Eligibility Criteria
Inclusion
- All preterm infants (\<33 weeks gestational age) from their 2nd week of life, receiving respiratory support via NCPAP
- expected to stay on NCPAP for the following 5 days at the NICU, Royal Hospital for Women, Randwick, Sydney
- provided written informed consent obtained from parents.
Exclusion
- Neonates with previous abdominal surgery
- Major congenital anomalies.
- \>33+0 weeks
- Less than 1 week of age
- Invasive ventilation
- Bilevel or Multilevel non-invasive ventilation
- Not expected respiratory support via CPAP for the following 5 days.
Key Trial Info
Start Date :
March 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06901206
Start Date
March 1 2025
End Date
June 1 2026
Last Update
March 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Newborn Intensive Care Unit, Royal Hospital for Women
Sydney, New South Wales, Australia, 2031